Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (171-180 of 645) with videos related to

Pageof 65
Sort By:
The European Respiratory Journal|October 13, 2018
Triple therapy <i>versus</i> single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysisMario Cazzola, Paola Rogliani, Luigino Calzetta, et al.
Respiratory Medicine|August 16, 2020
Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative reviewMaria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.
Expert Review of Clinical Pharmacology|June 30, 2020
The role of triple therapy in the management of COPDLuigino Calzetta, Maria Gabriella Matera, Paola Rogliani, et al.
Respiratory Medicine|August 16, 2021
Controversy surrounding the Sputnik V vaccineMario Cazzola, Paola Rogliani, Filomena Mazzeo, et al.
Expert Opinion on Drug Safety|May 30, 2024
An overview of the efficacy and safety of β<sub>2</sub>-adrenoceptor antagonists for the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 3, 2023
The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive updateMaria Gabriella Matera, Paola Rogliani, Giuseppe Novelli, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 28, 2024
Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular ImpactsMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.
Expert Opinion on Drug Discovery|June 30, 2023
An overview of the preclinical discovery and development of tezepelumab for the treatment of asthmaMaria Gabriella Matera, Josuel Ora, Paola Rogliani, et al.
Expert Opinion on Drug Discovery|April 23, 2014
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyondLuigino Calzetta, Paola Rogliani, Mario Cazzola, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 13, 2016
Assessing the viability of long-acting β<sub>2</sub>-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspectiveMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Pageof 65

Showing results (171-180 of 645) with videos related to

Sort By:
Pageof 65
The European Respiratory Journal|October 13, 2018
Triple therapy <i>versus</i> single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysisMario Cazzola, Paola Rogliani, Luigino Calzetta, et al.
Respiratory Medicine|August 16, 2020
Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative reviewMaria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.
Expert Review of Clinical Pharmacology|June 30, 2020
The role of triple therapy in the management of COPDLuigino Calzetta, Maria Gabriella Matera, Paola Rogliani, et al.
Respiratory Medicine|August 16, 2021
Controversy surrounding the Sputnik V vaccineMario Cazzola, Paola Rogliani, Filomena Mazzeo, et al.
Expert Opinion on Drug Safety|May 30, 2024
An overview of the efficacy and safety of β<sub>2</sub>-adrenoceptor antagonists for the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 3, 2023
The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive updateMaria Gabriella Matera, Paola Rogliani, Giuseppe Novelli, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 28, 2024
Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular ImpactsMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.
Expert Opinion on Drug Discovery|June 30, 2023
An overview of the preclinical discovery and development of tezepelumab for the treatment of asthmaMaria Gabriella Matera, Josuel Ora, Paola Rogliani, et al.
Expert Opinion on Drug Discovery|April 23, 2014
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyondLuigino Calzetta, Paola Rogliani, Mario Cazzola, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 13, 2016
Assessing the viability of long-acting β<sub>2</sub>-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspectiveMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Pageof 65